GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » E10

Theriva Biologics (FRA:SFY) E10 : €-59.64 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Theriva Biologics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Theriva Biologics's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.276. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-59.64 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 11.40% per year. During the past 5 years, the average E10 Growth Rate was 7.80% per year. During the past 10 years, the average E10 Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Theriva Biologics was 50.00% per year. The lowest was 3.40% per year. And the median was 23.20% per year.

As of today (2024-06-09), Theriva Biologics's current stock price is €0.2255. Theriva Biologics's E10 for the quarter that ended in Mar. 2024 was €-59.64. Theriva Biologics's Shiller PE Ratio of today is .


Theriva Biologics E10 Historical Data

The historical data trend for Theriva Biologics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics E10 Chart

Theriva Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -90.36 -66.48 -79.19 -73.26 -62.57

Theriva Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.75 -64.87 -63.30 -62.57 -59.64

Competitive Comparison of Theriva Biologics's E10

For the Biotechnology subindustry, Theriva Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theriva Biologics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theriva Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Theriva Biologics's Shiller PE Ratio falls into.



Theriva Biologics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Theriva Biologics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.276/131.7762*131.7762
=-0.276

Current CPI (Mar. 2024) = 131.7762.

Theriva Biologics Quarterly Data

per share eps CPI Adj_EPS
201406 -20.608 100.560 -27.005
201409 -21.728 100.428 -28.510
201412 -25.547 99.070 -33.981
201503 -54.979 99.621 -72.725
201506 -59.252 100.684 -77.550
201509 -37.423 100.392 -49.122
201512 -38.849 99.792 -51.300
201603 -37.717 100.470 -49.469
201606 -31.150 101.688 -40.367
201609 -28.487 101.861 -36.853
201612 -6.725 101.863 -8.700
201703 -6.545 102.862 -8.385
201706 -9.345 103.349 -11.915
201709 -41.111 104.136 -52.023
201712 6.506 104.011 8.243
201803 -5.271 105.290 -6.597
201806 -9.930 106.317 -12.308
201809 -7.970 106.507 -9.861
201812 -8.469 105.998 -10.529
201903 -2.213 107.251 -2.719
201906 -2.036 108.070 -2.483
201909 -2.815 108.329 -3.424
201912 -1.710 108.420 -2.078
202003 -1.810 108.902 -2.190
202006 -1.598 108.767 -1.936
202009 -1.189 109.815 -1.427
202012 -1.151 109.897 -1.380
202103 -1.092 111.754 -1.288
202106 -0.199 114.631 -0.229
202109 -0.213 115.734 -0.243
202112 -0.345 117.630 -0.386
202203 -0.281 121.301 -0.305
202206 -0.265 125.017 -0.279
202209 -0.303 125.227 -0.319
202212 -0.415 125.222 -0.437
202303 -0.280 127.348 -0.290
202306 -0.314 128.729 -0.321
202309 -0.178 129.860 -0.181
202312 -0.303 129.419 -0.309
202403 -0.276 131.776 -0.276

Add all the adjusted EPS together and divide 10 will get our e10.


Theriva Biologics  (FRA:SFY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Theriva Biologics E10 Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Theriva Biologics (FRA:SFY) Business Description

Traded in Other Exchanges
Address
9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-25-2022